PRIYADARSHAN BAJPAYI: Open Payments
NPI 1699087148 · MASSAPEQUA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$81,642 in 312 payments from 24 companies in 2025. Trend: 2023 $66,962 · 2024 $64,660 · 2025 $81,642
Speaker / faculty: $48,483Consulting: $12,520Honoraria: $9,351Food & beverage: $7,650Travel & lodging: $3,551Education: $87
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 47 | $27,006 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 49 | $20,044 |
| Janssen Pharmaceuticals, Inc | 33 | $16,178 |
| Axsome Therapeutics, Inc. | 15 | $10,470 |
| Otsuka America Pharmaceutical, Inc. | 23 | $5,123 |
| E.R. Squibb & Sons, L.L.C. | 27 | $510 |
| ABBVIE INC. | 22 | $500 |
| Teva Pharmaceuticals USA, Inc. | 21 | $390 |
| Lundbeck LLC | 20 | $365 |
| Neurocrine BioSciences, Inc. | 10 | $231 |
Products named: LYBALVI, CAPLYTA, SPRAVATO, Auvelity, REXULTI, COBENFY, VRAYLAR, ARISTADA.
Industry payments across NY — which companies pay providers there.
